- Home
- BKU vs RCKT Comparison
BKU vs RCKT Comparison
Compare BKU & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKU
- RCKT
- Stock Information
- Founded
- BKU 2009
- RCKT 1999
- Country
- BKU United States
- RCKT United States
- Employees
- BKU N/A
- RCKT N/A
- Industry
- BKU Savings Institutions
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- BKU Finance
- RCKT Health Care
- Exchange
- BKU Nasdaq
- RCKT Nasdaq
- Market Cap
- BKU 2.6B
- RCKT 326.4M
- IPO Year
- BKU 2011
- RCKT N/A
- Fundamental
- Price
- BKU $38.04
- RCKT $2.95
- Analyst Decision
- BKU Hold
- RCKT Buy
- Analyst Count
- BKU 11
- RCKT 13
- Target Price
- BKU $40.27
- RCKT $18.50
- AVG Volume (30 Days)
- BKU 814.6K
- RCKT 4.3M
- Earning Date
- BKU 07-23-2025
- RCKT 08-04-2025
- Dividend Yield
- BKU 3.26%
- RCKT N/A
- EPS Growth
- BKU 38.76
- RCKT N/A
- EPS
- BKU 3.21
- RCKT N/A
- Revenue
- BKU $972,198,000.00
- RCKT N/A
- Revenue This Year
- BKU $13.53
- RCKT N/A
- Revenue Next Year
- BKU $6.80
- RCKT N/A
- P/E Ratio
- BKU $11.84
- RCKT N/A
- Revenue Growth
- BKU 11.13
- RCKT N/A
- 52 Week Low
- BKU $28.21
- RCKT $2.19
- 52 Week High
- BKU $44.45
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- BKU 72.35
- RCKT 41.69
- Support Level
- BKU $35.16
- RCKT $2.40
- Resistance Level
- BKU $35.42
- RCKT $2.70
- Average True Range (ATR)
- BKU 0.81
- RCKT 0.21
- MACD
- BKU 0.38
- RCKT 0.15
- Stochastic Oscillator
- BKU 93.64
- RCKT 73.53
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.